ADMP logo

Adamis Pharmaceuticals (ADMP) Net Income

Annual Net Income

-$26.48 M
+$19.35 M+42.22%

December 31, 2022

Summary

Performance

1-Year Change

+42.22%

3-Year Change

+3.76%

5-Year Change

-3.68%

15-Year Change

-3.68%

ADMP Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$9.67 M
ADMP annual net profit is currently -373.77% below its historical high of $9.67 million

3-Year Low

-$45.83 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
ADMP previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
ADMP next annual earnings announcement has not yet been scheduled

OtherADMPprofitabilitymetrics:

Annual Net Margin

-556.73%
ADMP annual net profit margin is -556.73%

Annual Revenue

$4.76 M
ADMP annual revenue is $4.76 million

Annual Gross Profit

-$1.43 M
ADMP annual gross profit is -$1.43 million

Annual EPS

-$12.60
ADMP annual earnings per share is -$12.60

Quarterly Net Income

-$8.57 M
+$368.80 K+4.12%

June 30, 2023

Summary

Performance

3-Month Change

+4.12%

1-Year Change

-2.11%

3-Year Change

+33.66%

5-Year Change

+11.63%

ADMP Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$14.97 M
ADMP quarterly net profit is currently -157.26% below its historical high of $14.97 million

3-Year Low

-$10.35 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
ADMP previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
ADMP next earnings announcement has not yet been scheduled

OtherADMPprofitabilitymetrics:

Quarterly Net Margin

-123.46 K%
ADMP quarterly net profit margin is -123.46 thousand%

Quarterly Revenue

$6900.00
ADMP quarterly revenue is $6900.00

Quarterly Gross Profit

-$354.40 K
ADMP quarterly gross profit is -$354.40 thousand

Quarterly EPS

-$3.40
ADMP quarterly earnings per share is -$3.40

TTM Net Income

-$25.24 M
-$176.90 K-0.71%

June 30, 2023

Summary

Performance

3-Month Change

-0.71%

1-Year Change

+36.71%

3-Year Change

+18.73%

5-Year Change

+8.25%

ADMP TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$13.65 M
ADMP TTM net profit is currently -284.95% below its historical high of $13.65 million

3-Year Low

-$45.83 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
ADMP previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
ADMP next earnings announcement has not yet been scheduled

OtherADMPprofitabilitymetrics:

Annual Net Margin

-556.73%
ADMP annual net profit margin is -556.73%

TTM Revenue

$5.12 M
ADMP TTM revenue is $5.12 million

TTM Gross Profit

-$1.16 M
ADMP TTM gross profit is -$1.16 million

TTM EPS

-$11.80
ADMP TTM earnings per share is -$11.80

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$26.48 M
ADMP annual net profit is -$26.48 million

Annual Revenue

$4.76 M
ADMP annual revenue is $4.76 million

Annual Cost Of Goods Sold

$6.19 M
ADMP annual cost of goods sold is $6.19 million

Annual Operating Expenses

$23.63 M
ADMP annual total operating expenses is $23.63 million

Annual Interest Expense

-
ADMP annual interest expense value is unknown

Annual Income Tax

$2000.00
ADMP annual income tax is $2000.00

ADMP Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+42.2%-2.1%+36.7%
3 y3 years+3.8%+33.7%+18.7%
5 y5 years-3.7%+11.6%+8.3%

ADMP Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+73.1%+157.7%+20.8%+0.7%+81.5%
5 y5-yearat high+86.5%+157.7%+108.3%+0.7%+127.9%
alltimeall time-373.8%+86.5%-157.3%+124.5%-284.9%+127.9%

Adamis Pharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Jun 2023
-
-$8.57 M(-4.1%)
-$25.24 M(+0.7%)
Mar 2023
-
-$8.94 M(+168.8%)
-$25.07 M(-5.3%)
Dec 2022
-$26.48 M(-42.2%)
-$3.33 M(-24.4%)
-$26.48 M(-17.1%)
Sep 2022
-
-$4.40 M(-47.6%)
-$31.92 M(-20.0%)
Jun 2022
-
-$8.40 M(-18.9%)
-$39.89 M(-2.2%)
Mar 2022
-
-$10.35 M(+18.0%)
-$40.80 M(-11.0%)
Dec 2021
-$45.83 M(-7.2%)
-$8.77 M(-29.0%)
-$45.83 M(-16.5%)
Sep 2021
-
-$12.36 M(+32.7%)
-$54.91 M(+1.9%)
Jun 2021
-
-$9.31 M(-39.4%)
-$53.91 M(-6.3%)
Mar 2021
-
-$15.38 M(-13.9%)
-$57.52 M(+16.5%)
Dec 2020
-$49.39 M(+79.5%)
-$17.86 M(+57.2%)
-$49.39 M(+39.4%)
Sep 2020
-
-$11.36 M(-12.1%)
-$35.42 M(+14.0%)
Jun 2020
-
-$12.92 M(+78.4%)
-$31.06 M(+20.1%)
Mar 2020
-
-$7.25 M(+86.3%)
-$25.87 M(-6.0%)
Dec 2019
-$27.51 M(-29.5%)
-$3.89 M(-44.4%)
-$27.51 M(-24.5%)
Sep 2019
-
-$7.00 M(-9.5%)
-$36.43 M(-4.9%)
Jun 2019
-
-$7.74 M(-13.0%)
-$38.31 M(-4.9%)
Mar 2019
-
-$8.89 M(-30.6%)
-$40.28 M(+3.3%)
Dec 2018
-$39.01 M(+52.7%)
-$12.81 M(+44.3%)
-$39.01 M(+14.0%)
Sep 2018
-
-$8.88 M(-8.5%)
-$34.22 M(+6.6%)
Jun 2018
-
-$9.70 M(+27.4%)
-$32.12 M(+17.3%)
Mar 2018
-
-$7.62 M(-5.1%)
-$27.38 M(+7.2%)
Dec 2017
-$25.54 M(+31.4%)
-$8.03 M(+18.6%)
-$25.54 M(+40.5%)
Sep 2017
-
-$6.77 M(+36.2%)
-$18.18 M(+0.7%)
Jun 2017
-
-$4.97 M(-13.9%)
-$18.06 M(-4.0%)
Mar 2017
-
-$5.77 M(+761.4%)
-$18.80 M(-3.3%)
Dec 2016
-$19.44 M(+43.2%)
-$670.20 K(-89.9%)
-$19.44 M(-13.2%)
Sep 2016
-
-$6.64 M(+16.3%)
-$22.40 M(+18.5%)
Jun 2016
-
-$5.71 M(-10.8%)
-$18.91 M(+12.3%)
Mar 2016
-
-$6.41 M(+76.2%)
-$16.84 M(+24.1%)
Dec 2015
-$13.57 M(+45.7%)
-$3.64 M(+15.5%)
-$13.57 M(+36.6%)
Sep 2015
-
-$3.15 M(-13.6%)
-$9.93 M(+11.5%)
Jun 2015
-
-$3.64 M(+16.0%)
-$8.91 M(+9.4%)
Mar 2015
-
-$3.14 M(+47.9%)
-$8.15 M(-32.6%)
Dec 2014
-$9.32 M(+14.2%)
-
-
Sep 2014
-
-$2.12 M(-26.3%)
-$12.09 M(+20.9%)
Jun 2014
-
-$2.88 M(+85.6%)
-$9.99 M(+22.5%)
Mar 2014
-$8.16 M(+13.4%)
-$1.55 M(-71.9%)
-$8.16 M(-1.0%)
Dec 2013
-
-$5.53 M(>+9900.0%)
-$8.24 M(+75.9%)
Sep 2013
-
-$32.00 K(-96.9%)
-$4.69 M(-15.0%)
Jun 2013
-
-$1.04 M(-36.3%)
-$5.51 M(-23.4%)
Mar 2013
-$7.19 M(+46.4%)
-$1.64 M(-17.1%)
-$7.19 M(+6.4%)
Dec 2012
-
-$1.97 M(+130.2%)
-$6.76 M(+17.0%)
Sep 2012
-
-$857.50 K(-68.5%)
-$5.78 M(-9.7%)
Jun 2012
-
-$2.73 M(+126.1%)
-$6.40 M(+30.2%)
Mar 2012
-$4.92 M(-29.6%)
-$1.21 M(+21.7%)
-$4.92 M(+1.2%)
Dec 2011
-
-$991.30 K(-32.9%)
-$4.86 M(-30.2%)
Sep 2011
-
-$1.48 M(+19.1%)
-$6.96 M(+0.8%)
Jun 2011
-
-$1.24 M(+7.9%)
-$6.91 M(-1.0%)
Mar 2011
-$6.98 M(+4.1%)
-$1.15 M(-62.8%)
-$6.98 M(-32.6%)
Dec 2010
-
-$3.09 M(+117.0%)
-$10.36 M(+26.1%)
Sep 2010
-
-$1.43 M(+8.7%)
-$8.22 M(+12.1%)
Jun 2010
-
-$1.31 M(-71.0%)
-$7.33 M(+9.3%)
Mar 2010
-$6.71 M
-$4.53 M(+376.8%)
-$6.71 M(+169.9%)
Dec 2009
-
-$949.80 K(+75.9%)
-$2.49 M(+33.6%)
Sep 2009
-
-$540.10 K(-21.6%)
-$1.86 M(+13.3%)
Jun 2009
-
-$688.50 K(+124.3%)
-$1.64 M(+22.3%)
DateAnnualQuarterlyTTM
Mar 2009
-
-$307.00 K(-5.5%)
-$1.34 M(-12.5%)
Dec 2008
-$1.53 M(-20.4%)
-$324.90 K(+1.2%)
-$1.53 M(-15.3%)
Sep 2008
-
-$321.00 K(-17.5%)
-$1.81 M(0.0%)
Jun 2008
-
-$389.00 K(-21.9%)
-$1.81 M(-4.1%)
Mar 2008
-
-$498.00 K(-17.3%)
-$1.89 M(-2.0%)
Dec 2007
-$1.93 M(-119.9%)
-$602.10 K(+87.6%)
-$1.93 M(-114.1%)
Sep 2007
-
-$321.00 K(-31.1%)
$13.65 M(+10.7%)
Jun 2007
-
-$466.00 K(-13.2%)
$12.33 M(+6.8%)
Mar 2007
-
-$537.00 K(-103.6%)
$11.54 M(+18.6%)
Dec 2006
$9.67 M(-293.1%)
$14.97 M(-1013.0%)
$9.73 M(-235.1%)
Sep 2006
-
-$1.64 M(+31.1%)
-$7.20 M(-13.8%)
Jun 2006
-
-$1.25 M(-46.8%)
-$8.36 M(+267.9%)
Mar 2006
-
-$2.35 M(+19.8%)
-$2.27 M(-54.6%)
Dec 2005
-$5.01 M(-82.2%)
-$1.96 M(-29.7%)
-$5.01 M(-77.5%)
Sep 2005
-
-$2.79 M(-157.8%)
-$22.29 M(-1.5%)
Jun 2005
-
$4.83 M(-195.1%)
-$22.64 M(-25.0%)
Mar 2005
-
-$5.09 M(-73.6%)
-$30.18 M(+7.2%)
Dec 2004
-$28.15 M(+108.0%)
-$19.25 M(+512.3%)
-$28.15 M(+125.3%)
Sep 2004
-
-$3.14 M(+16.1%)
-$12.49 M(+3.9%)
Jun 2004
-
-$2.71 M(-11.4%)
-$12.02 M(-13.5%)
Mar 2004
-
-$3.06 M(-14.7%)
-$13.89 M(-0.5%)
Dec 2003
-$13.53 M(-15.1%)
-$3.58 M(+34.3%)
-$13.97 M(-4.9%)
Sep 2003
-
-$2.67 M(-41.7%)
-$14.69 M(+7.7%)
Jun 2003
-
-$4.58 M(+46.3%)
-$13.64 M(-7.1%)
Mar 2003
-
-$3.13 M(-27.2%)
-$14.68 M(-7.9%)
Dec 2002
-$15.94 M(-18.1%)
-$4.30 M(+165.1%)
-$15.94 M(-17.4%)
Sep 2002
-
-$1.62 M(-71.1%)
-$19.29 M(-10.4%)
Jun 2002
-
-$5.62 M(+28.2%)
-$21.54 M(+7.3%)
Mar 2002
-
-$4.39 M(-42.7%)
-$20.07 M(+3.1%)
Dec 2001
-$19.46 M(+70.5%)
-$7.66 M(+97.9%)
-$19.46 M(+25.1%)
Sep 2001
-
-$3.87 M(-6.9%)
-$15.56 M(+5.5%)
Jun 2001
-
-$4.16 M(+10.0%)
-$14.75 M(+11.0%)
Mar 2001
-
-$3.78 M(+0.6%)
-$13.28 M(+16.3%)
Dec 2000
-$11.42 M(+22.8%)
-$3.75 M(+22.7%)
-$11.42 M(+13.4%)
Sep 2000
-
-$3.06 M(+13.7%)
-$10.07 M(+13.0%)
Jun 2000
-
-$2.69 M(+40.5%)
-$8.91 M(+4.8%)
Mar 2000
-
-$1.92 M(-20.2%)
-$8.50 M(-8.5%)
Dec 1999
-$9.30 M(+26.3%)
-$2.40 M(+26.4%)
-$9.28 M(+6.1%)
Sep 1999
-
-$1.90 M(-16.7%)
-$8.75 M(-1.1%)
Jun 1999
-
-$2.28 M(-15.6%)
-$8.85 M(+0.9%)
Mar 1999
-
-$2.70 M(+44.7%)
-$8.77 M(+19.0%)
Dec 1998
-$7.37 M(-6.8%)
-$1.87 M(-6.7%)
-$7.37 M(-32.4%)
Sep 1998
-
-$2.00 M(-9.1%)
-$10.90 M(+13.5%)
Jun 1998
-
-$2.20 M(+69.2%)
-$9.60 M(+15.7%)
Mar 1998
-
-$1.30 M(-75.9%)
-$8.30 M(+5.1%)
Dec 1997
-$7.90 M(+132.4%)
-$5.40 M(+671.4%)
-$7.90 M(+154.8%)
Sep 1997
-
-$700.00 K(-22.2%)
-$3.10 M(-6.1%)
Jun 1997
-
-$900.00 K(0.0%)
-$3.30 M(-2.9%)
Mar 1997
-
-$900.00 K(+50.0%)
-$3.40 M(0.0%)
Dec 1996
-$3.40 M(+54.5%)
-$600.00 K(-33.3%)
-$3.40 M(-10.5%)
Sep 1996
-
-$900.00 K(-10.0%)
-$3.80 M(0.0%)
Jun 1996
-
-$1.00 M(+11.1%)
-$3.80 M(+52.0%)
Mar 1996
-
-$900.00 K(-10.0%)
-$2.50 M(+8.7%)
Dec 1995
-$2.20 M
-$1.00 M(+11.1%)
-$2.30 M(+76.9%)
Sep 1995
-
-$900.00 K(-400.0%)
-$1.30 M(+225.0%)
Jun 1995
-
$300.00 K(-142.9%)
-$400.00 K(-42.9%)
Mar 1995
-
-$700.00 K
-$700.00 K

FAQ

  • What is Adamis Pharmaceuticals annual net profit?
  • What is the all time high annual net income for Adamis Pharmaceuticals?
  • What is Adamis Pharmaceuticals annual net income year-on-year change?
  • What is Adamis Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Adamis Pharmaceuticals?
  • What is Adamis Pharmaceuticals quarterly net income year-on-year change?
  • What is Adamis Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Adamis Pharmaceuticals?
  • What is Adamis Pharmaceuticals TTM net income year-on-year change?

What is Adamis Pharmaceuticals annual net profit?

The current annual net income of ADMP is -$26.48 M

What is the all time high annual net income for Adamis Pharmaceuticals?

Adamis Pharmaceuticals all-time high annual net profit is $9.67 M

What is Adamis Pharmaceuticals annual net income year-on-year change?

Over the past year, ADMP annual net profit has changed by +$19.35 M (+42.22%)

What is Adamis Pharmaceuticals quarterly net profit?

The current quarterly net income of ADMP is -$8.57 M

What is the all time high quarterly net income for Adamis Pharmaceuticals?

Adamis Pharmaceuticals all-time high quarterly net profit is $14.97 M

What is Adamis Pharmaceuticals quarterly net income year-on-year change?

Over the past year, ADMP quarterly net profit has changed by -$176.90 K (-2.11%)

What is Adamis Pharmaceuticals TTM net profit?

The current TTM net income of ADMP is -$25.24 M

What is the all time high TTM net income for Adamis Pharmaceuticals?

Adamis Pharmaceuticals all-time high TTM net profit is $13.65 M

What is Adamis Pharmaceuticals TTM net income year-on-year change?

Over the past year, ADMP TTM net profit has changed by +$14.64 M (+36.71%)